ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
94,989.41
-2.77%
S&P 500
6,040.53
-0.50%
Dow Jones
44,544.66
-0.75%
US Dollar vs Yen
155.56
0.12%
Brent Oil
76.51
0.20%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE
  6. Hutchmed (china) Limited (HCM)

  7. Hutchmed (china) Limited (HCM) ニュース

HCM

Hutchmed (china) (HCM)

Hutchmed (china) Limited
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:HCM
日付受信時刻ニュースソース見出しコード企業名
2025/01/2818 : 00RNS Regulatory NewsHutchmed (China) Limited Overseas Regulatory AnnouncementLSE:HCMHutchmed (china) Limited
2025/01/1421 : 07Alliance NewsAlliance NewsIN BRIEF: Hutchmed lung cancer treatment Orpathys approved in ChinaLSE:HCMHutchmed (china) Limited
2025/01/1416 : 00RNS Non-RegulatoryHutchmed (China) Limited Full Approval for ORPATHYS in ChinaLSE:HCMHutchmed (china) Limited
2025/01/0219 : 46Alliance NewsAlliance NewsHutchmed China disposes of 45% stake in Shanghai joint ventureLSE:HCMHutchmed (china) Limited
2025/01/0216 : 01RNS Non-RegulatoryHutchmed (China) Limited China NDA Acceptance for ORPATHYS and TAGRISSOLSE:HCMHutchmed (china) Limited
2025/01/0216 : 00RNS Regulatory NewsHutchmed (China) Limited Overseas Regulatory AnnouncementLSE:HCMHutchmed (china) Limited
2025/01/0216 : 00RNS Regulatory NewsHutchmed (China) Limited US$608m Divestment of Non-Core Joint VentureLSE:HCMHutchmed (china) Limited
2024/12/3117 : 30RNS Regulatory NewsHutchmed (China) Limited Appointment of Joint Corporate BrokerLSE:HCMHutchmed (china) Limited
2024/12/3017 : 30RNS Regulatory NewsHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:HCMHutchmed (china) Limited
2024/12/1319 : 04Alliance NewsAlliance NewsIN BRIEF: Hutchmed to get Takeda milestone paymentLSE:HCMHutchmed (china) Limited
2024/12/1316 : 00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Receive Milestone Payment from TakedaLSE:HCMHutchmed (china) Limited
2024/12/1216 : 00RNS Non-RegulatoryHutchmed (China) Limited Breakthrough Therapy Designation in ChinaLSE:HCMHutchmed (china) Limited
2024/12/0321 : 19Alliance NewsAlliance NewsHutchmed China injection approval could be a "paradigm shift"LSE:HCMHutchmed (china) Limited
2024/12/0319 : 00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and Innovent Announce ELUNATE ApprovalLSE:HCMHutchmed (china) Limited
2024/11/2917 : 30RNS Regulatory NewsHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
2024/11/2819 : 32RNS Non-RegulatoryHutchmed (China) Limited Continued Inclusion of ORPATHYS in China NRDLLSE:HCMHutchmed (china) Limited
2024/11/2219 : 00Alliance NewsAlliance NewsHutchmed to get payment from Takeda as Fruzaqla launched in JapanLSE:HCMHutchmed (china) Limited
2024/11/2216 : 00RNS Non-RegulatoryHutchmed (China) Limited FRUZAQLA® Launched in Japan by TakedaLSE:HCMHutchmed (china) Limited
2024/11/2018 : 30RNS Regulatory NewsHutchmed (China) Limited Appointment of Independent Non-executive DirectorLSE:HCMHutchmed (china) Limited
2024/11/0616 : 00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ASH and ESMO AsiaLSE:HCMHutchmed (china) Limited
2024/10/3121 : 02Alliance NewsAlliance NewsHutchmed China receives first milestone payment for Takeda drug salesLSE:HCMHutchmed (china) Limited
2024/10/3117 : 30RNS Regulatory NewsHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
2024/10/3117 : 30RNS Non-RegulatoryHutchmed (China) Limited First Commercial Milestone PaymentLSE:HCMHutchmed (china) Limited
2024/10/2117 : 30RNS Regulatory NewsHutchmed (China) Limited Vesting of awards under the LTIPLSE:HCMHutchmed (china) Limited
2024/10/1617 : 52Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising resultsLSE:HCMHutchmed (china) Limited
2024/10/1615 : 00RNS Regulatory NewsHutchmed (China) Limited SAVANNAH: clinically meaningful response rateLSE:HCMHutchmed (china) Limited
2024/09/2416 : 49Alliance NewsAlliance NewsTakeda Pharmaceutical says Fruzaqla cancer drug gets Japan backingLSE:HCMHutchmed (china) Limited
2024/09/2416 : 00RNS Regulatory NewsHutchmed (China) Limited Japan Approval for FRUZAQLALSE:HCMHutchmed (china) Limited
2024/09/0915 : 00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ESMO and WCLCLSE:HCMHutchmed (china) Limited
2024/08/3020 : 24Alliance NewsAlliance NewsHutchmed "disappointed" as it withdraws fruquintinib applicationLSE:HCMHutchmed (china) Limited
 Showing the most relevant articles for your search:LSE:HCM

最近閲覧した銘柄

COIN
BTCUSD
Bitcoin
COIN
ADAUSD
Cardano
USOTC
ADDYY
Adidas (QX)
FX
USDEUR
US Dollar vs Euro
NYSE
DIS
Walt Disney
FX
USDGBP
US Dollar vs Sterling
PM
XAUUSD
Gold vs US Dollar
AMEX
SPY
SPDR S&P 500
COIN
XRPUSD
Ripple
NYSE
BAC
Bank of America
COIN
AVAXUSD
Avalanche
NASDAQ
GOOGL
Alphabet
USOTC
BNPQY
BNP Paribas (QX)
NYSE
AXP
American Express
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す